Numinus has announced a Phase 1 trial of a natural psilocybin product extracted and formulated at its company lab. The Vancouver-based company hopes that successful completion of the trial would allow for the product to be researched further via special access or compassionate access programs. “We believe there are several likely advantages to naturally occurring Psilocybintherapeutics that will…
